Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on March 14 and set a price target of $73.00.
In a report released on March 14, Stephen Baxter from Wells Fargo maintained a Buy rating on Humana (HUM – Research Report), with a price ...
West Yorkshire-based financial adviser, Robertson Baxter, has been acquired by financial planning business Benchmark Capital, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback